Skip to main content
ELAN
NYSE Life Sciences

Elanco Beats Q3 Estimates, Raises 2026 Guidance on Pet Health Strength

Tom Rudovsky · Reported by Benzinga
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$25.955
Mkt Cap
$12.968B
52W Low
$19.4
52W High
$27.98
52W Position info
34% above low
Off High info
7.2% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

ELAN sits 34% above its 52-week low of $19.4.

Summary

Elanco beat on both lines for Q3 2026: adjusted EPS of $0.27 versus $0.20 consensus and revenue of $1.265 billion, up 11.3% and ahead of the $1.208 billion estimate. Pet Health drove the quarter at $608 million, up 14%, with price up 5% and Zenrelia and Credelio Quattro taking share — Zenrelia posted its largest revenue quarter ever and U.S. sales more than doubled year over year. Management raised full-year 2026 adjusted EPS guidance to $1.17-$1.20 from $1.10-$1.16 and sales to $5.155-$5.180 billion from $5.090-$5.140 billion, both above consensus. The Q4 guide of $0.16-$0.19 EPS and $1.190-$1.215 billion in sales brackets the Street. Shares were up 8.97% at $25.80 on the print, and the company recommitted to its mid-single-digit organic revenue and low-double-digit EPS growth algorithm into 2027.

At the time of this announcement, ELAN was trading at $25.96 on NYSE in the Life Sciences sector, with a market capitalization of approximately $13B. The 52-week trading range was $19.40 to $27.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

ELAN - Latest Insights

ELAN
Nov 19, 2026, 6:35 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $27.45
Real-time Price: $25.22 info
Change: -$2.23 (-8%) info
Market Cap: $12.866B info
ELAN
Nov 06, 2026, 9:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.32
Real-time Price: $25.22 info
Change: +$0.8909 (+4%) info
Market Cap: $12.866B info
ELAN
Nov 06, 2026, 6:27 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.10
Real-time Price: $25.22 info
Change: +$1.12 (+5%) info
Market Cap: $12.866B info
ELAN
Nov 06, 2026, 6:27 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $24.10
Real-time Price: $25.22 info
Change: +$1.12 (+5%) info
Market Cap: $12.866B info
ELAN
Aug 07, 2026, 2:20 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $22.53
Real-time Price: $25.22 info
Change: +$2.69 (+12%) info
Market Cap: $12.866B info